TuisPACB • NASDAQ
add
Pacific Biosciences of California Inc
Vorige sluiting
$2,10
Dagwisseling
$1,97 - $2,15
Jaarwisseling
$1,16 - $7,85
Markkapitalisasie
575,11 m USD
Gemiddelde volume
8,53 m
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Inkomste | 39,97 m | -28,23% |
Bedryfskoste | 69,21 m | -24,66% |
Netto inkomste | -60,72 m | 9,19% |
Netto winsgrens | -151,94 | -26,54% |
Wins per aandeel | -0,17 | 37,04% |
EBITDA | -44,96 m | 35,71% |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 471,15 m | -38,64% |
Totale bates | 1,45 mjd | -23,62% |
Totale aanspreeklikheid | 996,93 m | -12,13% |
Totale ekwiteit | 453,12 m | — |
Uitstaande aandele | 273,86 m | — |
Prys om te bespreek | 1,27 | — |
Opbrengs op bates | -9,46% | — |
Opbrengs op kapitaal | -10,03% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Sep. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -60,72 m | 9,19% |
Kontant van bedrywe | -45,46 m | 30,25% |
Kontant van beleggings | 23,06 m | -90,48% |
Kontant van finansiering | 812,00 k | 203,97% |
Netto kontantverandering | -21,59 m | -112,24% |
Beskikbare kontantvloei | -13,40 m | 88,84% |
Meer oor
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
Gestig
2004
Webwerf
Werknemers
796
